Traitement des tumeurs germinales de l’ovaire

  • P. Pautier
  • C. Lhommé
Part of the Abord clinique book series (ONCOLPRAT)


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Talerman A (1995) Germ cell tumors of the ovary, in Kurman R (ed): Blaustein’s Pathology of the Female Genital Tract (ed 4). Springer-Verlag, New York, p 849–914Google Scholar
  2. 2.
    Norris HJ, Jensen RD (1972) Relative frequency of ovarian neoplasms in children and adolescents. Cancer 30: 713–9PubMedGoogle Scholar
  3. 3.
    Tewari K, Cappuccini F, Disaia PJ et al. (2000) Malignant germ cell tumors of the ovary. Obstet Gynecol 95: 128–33CrossRefPubMedGoogle Scholar
  4. 4.
    Tangir J, Zelterman D, Ma W et al. (2003) Reproductive function after conservative surgery and chemotherapy for malignant germ cell tumors of the ovary. Obstet Gynecol 101: 251–57CrossRefPubMedGoogle Scholar
  5. 5.
    International Federation of Gynecology and Obstetrics (1987) Change in definitions of clinical staging for carcinoma of the cervix and ovary. Am J Obstet Gynecol 156: 236Google Scholar
  6. 6.
    Herrin VE, Thigpen JT (2000) Germ cell Tumors of Ovary. In: D. Raghavan, ML Brecher, DH Johnson, NJ Meropol, PL Moots, JT Thigpen, ed. in Textbook of uncommon cancer. J Wiley and Sons Ed, West Sussex, England, p 671–80Google Scholar
  7. 7.
    Culine S, Lhommé C, Kattan J et al. (1995). Cisplatin-based chemotherapy in dysgerminoma of the ovary: thirteen-year experience at the Institut Gustave-Roussy. Gynecol Oncol 58: 344–8CrossRefPubMedGoogle Scholar
  8. 8.
    Williams SD, Gershenson DM, Horowitz CJ et al. (1997) Ovarian Germ-cell Tumors. In Principles and practice of Gynecologic Oncology, Hoskins WJ, Perez CA and Young RC, Lippincott-Raven ed, Philadelphia New-York, p 987–1001Google Scholar
  9. 9.
    Slayton RE, Park RC, Silverberg SG et al. (1985) Vincristine, dactinomycin and cyclophosphamide in the treatment of malignant germ cell tumors of the ovary. A Gynecologic Oncology Group study (a final report). Cancer 56: 243–8PubMedGoogle Scholar
  10. 10.
    Williams SD, Blessing JA, Liao SY et al. (1994) Adjuvant therapy of ovarian germ cell tumors with cisplatin, etoposide and bleomycin: a trial of the Gynecologic Oncology Group. J Clin Oncol 12: 701–6PubMedGoogle Scholar
  11. 11.
    Williams SD, Blessing JA, Moore DH et al. (1989) Cisplatin, Vin-blastine and Bleomycin in advanced and recurrent ovarian germ cell tumors. A trial of the Gynecologic Oncology Group. Ann Intern Med 111: 22–7PubMedGoogle Scholar
  12. 12.
    Culine S, Berton D, Rey A et al. (1996) Prognostic factors for survival in chemotherapy treated ovarian germ cell tumors. 32th Annual Meeting American Society of Clinical Oncology. Proc ASCO 15: 294Google Scholar
  13. 13.
    André F, Fizazi K, Culine S et al. (2000) The growing teratoma syndrome: results of therapy and long-term fol-low-up of 33 patients. Eur J Cancer 36: 1389–94CrossRefPubMedGoogle Scholar
  14. 14.
    Low JJ, Perrin LC, Crandon AJ et al. (2000) Conservative surgery to preserve ovarian function in patients with malignant ovarian germ cell tumors. A review of 74 cases. Cancer 89: 391–8CrossRefPubMedGoogle Scholar
  15. 15.
    Zanetta G, Bonazzi C, Cantu M et al. (2001) Survival and reproductive function after treatment of malignant germ cell ovarian tumors. J Clin Oncol 19: 1015–20PubMedGoogle Scholar
  16. 16.
    Casey AC, Bhadauria S, Shapter A et al. (1996) Dysgerminoma: the role of conservative surgery. Gynecol Oncol 63: 352–7CrossRefPubMedGoogle Scholar
  17. 17.
    Gershenson DM, Copeland IJ, Del Jungo G (1986) Second look laparotomy in the management of malignant germ cell tumors of the ovary. Obstet Gynecol 67: 789–93PubMedGoogle Scholar
  18. 18.
    Culine S, Lhommé C, Michel G et al. (1996) Is there a role for second look laparotomy in the management of malignant germ cell tumors of the ovary? Experience at Institut Gustave-Roussy. J Surg Oncol 62: 40–5CrossRefPubMedGoogle Scholar
  19. 19.
    Gerbaulet a, Gandon C, Lusinchi A et al. (1988) Le séminome ovarien. Place de la radiothérapie. Expérience de l’institut Gustave-Roussy. Société franćaise de radiologie. J Eur Radiother 9: 134Google Scholar
  20. 20.
    De Palo G, Pilotti S, Kenda R et al. (1987) Germ cell tumors of the ovary: the experience of the National Cancer Insitute of Milan. I. Dysgerminoma. Int J Radiat Biol Phys 13: 853–60Google Scholar
  21. 21.
    Culine S, Lhommé C, Droz JP (1997). Traitement médical des tumeurs germinales malignes de l’ovaire de l’adulte. Bull Cancer 84: 919–21PubMedGoogle Scholar
  22. 22.
    Culine S, Kattan J, Lhommé C et al. (1994) A phase II study of high-dose Cisplatin, Vinblastine, Bleomycin, and Etoposide (PVeBV regimen) in malignant nondysgerminomatous germ-cell tumors of the ovary. Gynecol Oncol 54: 47–53CrossRefPubMedGoogle Scholar
  23. 23.
    Culine S, Lhommé C, Kattan J et al. (1994) Long-term results of two VAB-like regimens (vinblastine + actinomycine-D + bléomycine + cyclophosphamide + cisplatine) in malignant germ cell tumours of the ovary. Eur J Cancer 30A: 1239–44PubMedGoogle Scholar
  24. 24.
    Williams SD, Birch R, Einhorn LH et al. (1987) Disseminated germ cell tumors: chemotherapy with cisplatin, bleomycin plus either vinblastine or etoposide. N Engl J Med 316: 1434–40Google Scholar
  25. 25.
    Gershenson DM, Morris M, Cangir A (1990) Treatment of malignant germ cell tumors of the ovary with bleomycin, etoposide and cisplatin. J Clin Oncol 8: 715–20PubMedGoogle Scholar
  26. 26.
    Williams SD, Kauderer J, Burnett AF et al. (2004) Adjuvant therapy of completely resected dysgerminoma with carboplatin and etoposide: a trial of the Gynecologic Oncology Group. Gynecol Oncol 95: 496–9CrossRefPubMedGoogle Scholar
  27. 27.
    Gershenson DM (1988) Menstrual and reproductive function after treatment with combination chemotherapy for malignant ovarian germ cell tumors. J Clin Oncol 6: 270–5PubMedGoogle Scholar
  28. 28.
    Gershenson DM, Kavanagh JJ, Copeland LJ et al. (1986) Treatment of malignant nondysgerminomatous germ cell tumors of the ovary with vinblastine, bleomycin, and cisplatine. Cancer 57: 1731–7PubMedGoogle Scholar
  29. 29.
    Segelov E, Campbell J, Ng M et al. (1994) Cisplatin-based chemotherapy for ovarian germ cell malignancies: the Australian experience. J Clin Oncol 12: 378–84PubMedGoogle Scholar
  30. 30.
    Mayordomo JI, Paz-Ares L, Rivera F et al. (1994) Ovarian and extragonadal malignant germ-cell tumors in females: a single-institution experience with 43 patientes. Ann Oncol 5: 225–31PubMedGoogle Scholar
  31. 31.
    Bower M, Fife K, Holden L et al. (1996) Chemotherapy for ovarian germ cell tumours. Eur J Cancer 32A: 593–7PubMedGoogle Scholar
  32. 32.
    Mitchell PL, Al-Nasri N, A’Hern R et al. (1999) Treatment of nondysgerminomatous ovarian germ cell tumors. An analysis of 69 cases. Cancer 85: 2232–44CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag France 2006

Authors and Affiliations

  • P. Pautier
  • C. Lhommé

There are no affiliations available

Personalised recommendations